MSS116 Antibody

What is MSS116 and why is it important in scientific research?

MSS116 is a DEAD-box RNA helicase protein primarily found in Saccharomyces cerevisiae (baker's yeast) that plays multiple crucial roles in mitochondrial function. Originally identified in genetic screens for nucleus-encoded factors involved in splicing of intron-containing mitochondrial transcripts, MSS116 has been extensively studied for its role in the splicing of all mitochondrial group I and group II introns present in three mitochondrial genes: COX1, COB, and 21S rRNA . Beyond splicing, research has revealed MSS116 functions in mitochondrial transcription elongation (particularly under cold stress), mitoribosome biogenesis, and mitochondrial translation . Its multifunctional character makes MSS116 a focal point for understanding mitochondrial gene expression, RNA processing, and protein synthesis mechanisms in eukaryotes. Antibodies against MSS116 enable researchers to study its localization, interactions, and functions in various experimental contexts.

What are the different functional roles of MSS116 that can be studied using specific antibodies?

MSS116 exhibits several distinct functions in mitochondria that researchers can investigate using antibodies:

• RNA Splicing: MSS116 functions as an RNA chaperone that promotes efficient splicing of mitochondrial introns in an ATP-dependent manner . Antibodies can be used to study this splicing machinery through co-immunoprecipitation of splicing complexes.

• Transcription Elongation: Under cold stress conditions, MSS116 modulates mitochondrial RNA-polymerase activity during transcription elongation, though interestingly, this occurs in an ATP-independent fashion . Antibodies can help visualize MSS116 association with transcription machinery.

• Mitoribosome Assembly: MSS116 interacts with the mitoribosome assembly factor Mrh4 and associates with the 54S large mitoribosomal subunit (mtLSU) . Antibodies are valuable for tracking these associations through co-sedimentation experiments.

• Translation Regulation: MSS116 specifically regulates COX1 mRNA translation through interactions with the translational activator Pet309 . Antibody-based detection methods can reveal these protein-protein interactions.

These diverse roles can be studied with antibodies through various techniques including immunoblotting, immunoprecipitation, and sucrose gradient fractionation experiments.

How are MSS116 antibodies typically generated for research applications?

MSS116 antibodies for research are typically generated using one of two main approaches:

• Peptide-derived antibodies: As demonstrated in published research, antibodies against MSS116 can be generated by selecting specific peptide sequences unique to the protein. Researchers have successfully produced antibodies against MSS116 peptides that effectively recognize the protein in mitochondrial extracts . This approach allows for targeted antibody development against specific regions of interest in the MSS116 protein.

• Tag-based detection systems: In cases where generating antibodies against the native protein proves challenging, researchers have employed epitope tagging strategies. For example, experiments have utilized His-tagged versions of MSS116, which can be detected using commercial anti-His antibodies . This approach has been successfully employed to measure MSS116 expression levels in overexpression studies through both flow cytometry and immunofluorescence techniques .

The choice between these approaches depends on the specific research questions and experimental design considerations. Peptide-derived antibodies offer specificity for the native protein, while tag-based systems may provide higher sensitivity and versatility across different experimental platforms.

What are the optimal protocols for using MSS116 antibodies in Western blotting?

When using MSS116 antibodies for Western blotting, researchers should consider the following optimized protocol based on published methodologies:

• Sample Preparation:

  • Isolate mitochondria using standard differential centrifugation techniques

  • Solubilize mitochondrial proteins in buffer containing 0.8% Triton X-100 and 25 mM KCl

  • Include protease inhibitors to prevent degradation during sample processing

• Protein Separation and Transfer:

  • Use 10-12% SDS-PAGE gels for optimal resolution of MSS116 (approximately 76 kDa)

  • Transfer to PVDF membranes at 100V for 1 hour or 30V overnight at 4°C

• Antibody Incubation:

  • Block membranes with 5% non-fat dry milk in TBS-T for 1 hour at room temperature

  • For peptide-derived MSS116 antibodies, typical dilutions range from 1:1000 to 1:5000

  • For tagged versions of MSS116, anti-tag antibodies (e.g., anti-His) can be used at dilutions of approximately 1:10000

  • Incubate with primary antibody overnight at 4°C

• Detection and Visualization:

  • Use appropriate HRP-conjugated secondary antibodies (typically 1:5000 to 1:10000 dilution)

  • Develop using enhanced chemiluminescence (ECL) reagents

  • Expected molecular weight of MSS116 is approximately 76 kDa

These parameters should be optimized for each specific antibody preparation and experimental context.

How can researchers effectively use MSS116 antibodies for immunoprecipitation experiments?

For effective immunoprecipitation (IP) of MSS116 and its interacting partners, researchers should follow these methodological guidelines:

• Mitochondrial Extract Preparation:

  • Isolate mitochondria from yeast cells using standard protocols

  • Solubilize mitochondrial membranes using mild detergents (0.8-1.0% Triton X-100) in buffers containing 25-50 mM KCl

  • Include RNase inhibitors (e.g., RNaseOUT at 200 U) if studying RNA-protein interactions

• Pre-clearing and Antibody Binding:

  • Pre-clear lysates with Protein A/G beads to reduce non-specific binding

  • Incubate clarified lysates with MSS116 antibodies (typically 2-5 μg per mg of protein)

  • Allow binding to occur overnight at 4°C with gentle rotation

• Capturing Immune Complexes:

  • Add pre-equilibrated Protein A/G beads to capture antibody-antigen complexes

  • Wash extensively with decreasing detergent concentrations to preserve protein-protein interactions

  • For RNA-protein interactions, include magnesium in washing buffers (e.g., 20 mM MgCl₂)

• Elution and Analysis:

  • Elute bound proteins by boiling in SDS sample buffer

  • Analyze by western blotting for MSS116 and potential interacting partners

  • For RNA analysis, extract RNA from immunoprecipitates for RT-PCR or RNA-seq

This approach has successfully identified interactions between MSS116 and other proteins such as Mrh4, Pet309, and mitoribosomal components .

What controls should be included when using MSS116 antibodies in experimental procedures?

To ensure reliable and interpretable results when using MSS116 antibodies, researchers should incorporate the following essential controls:

• Genetic Controls:

  • Δmss116 strain extracts as a negative control to confirm antibody specificity

  • Strains overexpressing MSS116 as positive controls for antibody sensitivity calibration

  • Strains expressing tagged versions of MSS116 when working with anti-tag antibodies

• Immunoblotting Controls:

  • Pre-immune serum controls to assess non-specific binding

  • Peptide competition assays where the immunizing peptide is pre-incubated with the antibody

  • Loading controls using antibodies against stable mitochondrial proteins (e.g., porin)

• Immunoprecipitation Controls:

  • IP with non-specific IgG or pre-immune serum to identify non-specific binding

  • IP from Δmss116 strain extracts to identify false positives

  • Reciprocal IP of identified interaction partners to confirm associations

  • RNase treatment controls when studying RNA-dependent interactions

• Functional Validation:

  • Correlation of antibody signal with physiological changes in different conditions

  • Fractionation experiments to confirm mitochondrial localization

  • Complementary approaches like fluorescence microscopy with tagged versions

These controls are crucial for establishing the specificity of antibody-based detection and ensuring that observed interactions and localizations genuinely reflect MSS116 biology rather than experimental artifacts.

How can researchers use MSS116 antibodies to investigate mitoribosome assembly?

MSS116 antibodies provide powerful tools for investigating the protein's role in mitoribosome assembly through several advanced techniques:

• Sucrose Gradient Sedimentation Analysis:

  • Researchers can extract mitochondrial proteins using 0.8% Triton X-100 and analyze them through 10-30% sucrose gradients

  • By centrifuging at 40,000 rpm for 1.5 hours and collecting 28 fractions, researchers can track where MSS116 co-sediments with mitoribosomal components

  • Under conditions with 0.5 mM MgCl₂, MSS116 antibodies can detect the protein's association with fully assembled ribosomes

  • When using EDTA-containing buffers that dissociate ribosomes, MSS116 preferentially co-sediments with the 54S mtLSU

• Comparative Proteomics of Mitoribosome Components:

  • MSS116 antibodies can help quantify changes in mitoribosomal protein levels between wild-type and Δmss116 strains

  • Late-assembly riboproteins such as bL32, uL16, and bL33 show the most prominent reductions in Δmss116 mitochondria, suggesting MSS116's involvement in early assembly steps

  • Immunoblotting of fractionated mitoribosomal proteins can reveal specific assembly intermediates affected by MSS116 absence

• RNA-Protein Association Studies:

  • RNA immunoprecipitation (RIP) using MSS116 antibodies can identify mitoribosomal RNA components that directly interact with MSS116

  • Subsequent RT-PCR analysis can determine if MSS116 preferentially associates with specific mitochondrial rRNAs during assembly processes

These approaches collectively provide a comprehensive view of MSS116's contribution to mitoribosome assembly, enabling researchers to dissect the temporal and mechanistic aspects of its function in this process.

What experimental approaches can determine MSS116's interactions with other mitochondrial factors?

To characterize MSS116's interactions with other mitochondrial factors, researchers can employ several sophisticated experimental approaches:

• Affinity Purification-Mass Spectrometry (AP-MS):

  • Immunoprecipitate MSS116 using specific antibodies under various buffer conditions to preserve different types of interactions

  • Analyze co-purifying proteins by mass spectrometry to identify interaction partners

  • This approach has successfully identified MSS116's interactions with mitoribosomal proteins, Mrh4, degradosome components (Suv3 and Dss1), and the 21S rRNA methyltransferase Mrm1

• Conditional Interaction Studies:

  • Compare MSS116 interaction partners under different conditions (e.g., respiratory vs. fermentative growth)

  • Analyze how interactions change in strains with mutations affecting specific MSS116 functions (e.g., helicase-dead mutants)

  • Research shows that mutations abolishing MSS116's helicase activity do not prevent interaction with Pet309 but affect COX1 translation, revealing functional significance of these interactions

• Spatial Proximity Analysis:

  • Use proximity ligation assays with MSS116 antibodies to visualize interactions in situ

  • Combine with subcellular fractionation to determine where within mitochondria these interactions occur

  • Correlate with functional assays to determine the physiological relevance of observed interactions

• Genetic Interaction Mapping:

  • Combine MSS116 antibody-based biochemical approaches with genetic studies

  • Examine how overexpression or deletion of interaction partners affects MSS116 functions

  • Studies show that multiple copies of MRH4 do not suppress respiratory defects in Δmss116 mutants, suggesting non-overlapping functions despite physical interaction

These multifaceted approaches provide complementary information about MSS116's interaction network and help distinguish direct from indirect interactions.

How can MSS116 antibodies be used to study its role in mitochondrial translation?

MSS116 antibodies enable sophisticated analyses of the protein's role in mitochondrial translation through several methodological approaches:

• Polysome Profiling:

  • Extract mitochondrial ribosomes under conditions that preserve translation complexes (low salt, presence of cycloheximide)

  • Fractionate extracts on 10-30% sucrose gradients and analyze fractions by western blotting with MSS116 antibodies

  • Simultaneously analyze RNA content of fractions by RT-PCR to determine which mRNAs co-sediment with MSS116

  • This approach has revealed MSS116's association with actively translating ribosomes and specific mRNAs like COX1

• Translation Activator Complex Analysis:

  • Use MSS116 antibodies for co-immunoprecipitation experiments to isolate translation activator complexes

  • Western blot for known translational activators like Pet309, which interacts with MSS116

  • Comparative analysis between wild-type and mutant strains has shown that Pet309 levels are virtually absent in Δmss116 strains, explaining translation defects

• Pulse Labeling of Mitochondrial Translation Products:

  • Perform in vivo labeling of mitochondrial translation products with 35S-methionine in the presence of cycloheximide (to inhibit cytoplasmic translation)

  • Compare patterns and intensities of labeled proteins between wild-type and Δmss116 strains

  • Correlate translation patterns with immunoblotting results for MSS116 and its interaction partners

  • Research shows markedly lowered synthesis of Cox1 in Δmss116 mitochondria, consistent with MSS116's role in COX1 mRNA translation

• Analysis of Translation Initiation vs. Elongation:

  • Use MSS116 antibodies to track the protein's association with translation complexes at different stages

  • Studies demonstrate that MSS116 is required for both initiation and elongation phases of COX1 mRNA translation

  • Combine with ribosome profiling to determine the exact position of ribosomes on mRNAs in the presence or absence of MSS116

These methodologies collectively provide a comprehensive view of MSS116's multifaceted roles in mitochondrial translation, particularly its specific effects on COX1 mRNA.

What are common issues with MSS116 antibody specificity and how can they be addressed?

Researchers working with MSS116 antibodies may encounter several specificity challenges that require methodological solutions:

• Cross-reactivity with Related DEAD-box Helicases:

  • Issue: Antibodies may recognize conserved domains present in multiple DEAD-box proteins

  • Solution: Use peptide-derived antibodies targeting unique regions of MSS116

  • Validation: Always include Δmss116 control samples to confirm the absence of signal

  • Alternative: When possible, use epitope-tagged versions of MSS116 with highly specific commercial antibodies against the tag

• Background Signals in Mitochondrial Extracts:

  • Issue: Mitochondrial extracts contain abundant proteins that may create non-specific background

  • Solution: Optimize blocking conditions (5% milk or BSA) and increase washing stringency

  • Validation: Compare wild-type signal intensity to Δmss116 background

  • Alternative: Pre-absorb antibodies with Δmss116 extracts to remove cross-reactive antibodies

• Detection of Degradation Products:

  • Issue: MSS116 may undergo partial proteolysis during extraction

  • Solution: Include comprehensive protease inhibitor cocktails during sample preparation

  • Validation: Compare fresh samples to those subjected to intentional degradation

  • Analysis: Document and characterize all immunoreactive bands to distinguish genuine degradation products from non-specific signals

• Antibody Batch Variation:

  • Issue: Different antibody preparations may have varying specificity profiles

  • Solution: Thoroughly validate each new batch against previously characterized lots

  • Documentation: Maintain detailed records of antibody performance across experimental conditions

  • Standardization: Use quantitative standards (purified protein or synthetic peptides) to normalize detection sensitivity

Addressing these issues requires systematic optimization and validation steps tailored to each experimental system and antibody preparation.

How should experiments be designed to distinguish between MSS116's multiple functions?

To differentiate between MSS116's distinct functional roles, researchers should employ targeted experimental designs:

• Genetic Background Selection:

  • Use intronless mtDNA strains to eliminate splicing-related functions when studying translation or ribosome assembly

  • Engineer strains with nuclear-encoded VAR1 to prevent confounding effects of impaired mitoribosomal assembly on Var1 synthesis

  • Control growth temperature carefully, as MSS116's transcription elongation function is particularly important at low temperatures (16°C)

• Domain-Specific Mutations:

  • Compare strains expressing MSS116 variants with mutations in specific functional domains:

    • Helicase-dead mutants maintain some protein-protein interactions but lose RNA remodeling capabilities

    • RNA-binding mutants help distinguish between physical scaffold functions and enzymatic activities

  • Use antibodies to confirm equivalent expression levels of mutant proteins

• Biochemical Separation of Functions:

  • Vary extraction conditions to preserve different types of interactions:

    • EDTA conditions disrupt ribosome assembly and allow study of MSS116's association with isolated mtLSU

    • Magnesium-containing buffers preserve intact ribosomes and translation complexes

  • Use sucrose gradient fractionation to physically separate different MSS116-containing complexes

• Temporal Analysis:

  • Design time-course experiments to distinguish early events (splicing, ribosome assembly) from later ones (translation)

  • Use inducible expression systems to control when MSS116 is present and study the sequence of events

• Interactor-Specific Analysis:

  • Focus on specific known interactors to isolate particular functions:

    • Mrh4 interactions relate to mitoribosome assembly

    • Pet309 interactions specifically connect to COX1 translation

These experimental strategies help isolate and characterize MSS116's individual functions while controlling for interdependencies between its various roles.

What experimental conditions might affect MSS116 antibody performance?

Several experimental conditions can significantly impact MSS116 antibody performance, requiring careful optimization:

• Buffer Composition Effects:

  • Detergent concentration: Higher concentrations (>1% Triton X-100) may expose epitopes but can disrupt protein-protein interactions

  • Salt concentration: Buffers with 25-50 mM KCl preserve MSS116 interactions, while higher salt may reduce non-specific binding but disrupt genuine interactions

  • Divalent cations: Presence of MgCl₂ (0.5-20 mM) affects ribosome integrity and MSS116 association patterns

• Sample Preparation Variables:

  • Mitochondrial isolation method: Mechanical disruption versus enzymatic spheroplasting affects membrane integrity

  • Protease inhibitor selection: Complete inhibitor cocktails prevent epitope degradation

  • Sample handling time: Minimize to prevent degradation or artificial redistribution of MSS116

• Epitope Accessibility Considerations:

  • Fixation effects: For immunofluorescence, optimization of fixative type and concentration is critical

  • Denaturation conditions: For Western blotting, SDS concentration and heating duration affect epitope exposure

  • Antibody incubation temperature: Room temperature versus 4°C can affect specificity and sensitivity

• Experimental System Variations:

  • Growth conditions: MSS116 expression and localization patterns change with carbon source and temperature

  • Cell cycle stage: Mitochondrial biogenesis varies through the cell cycle, potentially affecting MSS116 levels

  • Strain background: Different yeast strains may show variation in MSS116 expression levels and antibody accessibility

• Technical Optimization Table:

Researchers should systematically optimize these conditions when implementing MSS116 antibody-based methods in their specific experimental systems.

How can MSS116 antibodies contribute to studies of mitochondrial stress responses?

MSS116 antibodies offer valuable tools for investigating mitochondrial stress responses through several innovative approaches:

• Monitoring MSS116 Expression Changes During Stress:

  • Use quantitative immunoblotting to track MSS116 protein levels under various stress conditions

  • Research indicates that MSS116 overexpression itself can trigger stress responses resembling those seen in intronless (I⁰) yeast strains

  • Measure MSS116 levels during temperature shifts, oxidative stress, or mitochondrial translation inhibition to establish correlation with stress markers

• Analyzing MSS116 Interactions Under Stress Conditions:

  • Employ co-immunoprecipitation with MSS116 antibodies to identify stress-specific interaction partners

  • Compare immunoprecipitated complexes from normal and stress conditions using mass spectrometry

  • Investigate whether MSS116 forms stress granule-like structures in mitochondria during specific stresses

• Retrograde Signaling Studies:

  • Research shows that MSS116 overexpression phenotypes require a functional retrograde response pathway dependent on Rtg2

  • Use MSS116 antibodies alongside markers of retrograde signaling to determine whether MSS116 directly participates in stress signal transmission

  • Compare wild-type to rtg2-deleted strains to differentiate direct and indirect effects of MSS116 on stress responses

• Mitochondrial Quality Control Assessment:

  • Track MSS116 association with quality control machinery during stress responses

  • Determine whether MSS116 levels or subcellular distribution changes during mitochondrial degradation processes

  • Evaluate whether MSS116's helicase activity participates in resolving stress-induced RNA/DNA damage

These approaches can reveal previously unknown connections between MSS116 functions and cellular stress adaptation mechanisms, particularly in the context of mitochondrial homeostasis maintenance.

What techniques can combine MSS116 antibodies with RNA analysis to study RNA-protein interactions?

Researchers can employ several sophisticated techniques that combine MSS116 antibodies with RNA analysis to characterize its RNA-protein interactions:

• RNA Immunoprecipitation (RIP) with MSS116 Antibodies:

  • Immunoprecipitate MSS116 under conditions that preserve RNA-protein interactions

  • Extract RNA from immunoprecipitates and analyze by RT-PCR or RNA-seq

  • This approach has been used to identify MSS116 association with COX1 and COB mRNAs

  • Include RNase inhibitors (e.g., RNaseOUT) in extraction buffers to preserve RNA integrity

• UV Crosslinking Immunoprecipitation (CLIP):

  • UV-crosslink RNA-protein complexes in vivo to capture direct interactions

  • Immunoprecipitate MSS116 using specific antibodies

  • Partially digest RNA and sequence remaining protected fragments

  • Map binding sites at nucleotide resolution to identify MSS116 binding motifs

• Gradient Fractionation with Dual RNA-Protein Analysis:

  • Fractionate mitochondrial extracts on sucrose gradients

  • Analyze each fraction by both:
    a) Western blotting with MSS116 antibodies
    b) RT-PCR for specific mitochondrial transcripts

  • Correlate MSS116 protein distribution with RNA profiles to identify co-migration patterns

• In Vitro Reconstitution with Purified Components:

  • Use MSS116 antibodies to immunopurify native protein for in vitro studies

  • Combine with labeled RNA substrates to study unwinding activity

  • Compare wild-type MSS116 to helicase-dead variants to distinguish binding from remodeling activities

These combined approaches provide complementary information about which RNAs interact with MSS116, the nature of those interactions, and their functional consequences in mitochondrial gene expression regulation.

How might MSS116 antibodies facilitate comparative studies across different yeast species?

MSS116 antibodies can enable valuable comparative studies across yeast species, providing insights into evolutionary conservation and specialization:

• Cross-Species Epitope Recognition Analysis:

  • Test whether antibodies raised against S. cerevisiae MSS116 recognize orthologs in other yeast species

  • Create an epitope conservation map by aligning MSS116 sequences across species and correlating with antibody reactivity

  • For species where direct recognition fails, develop species-specific antibodies targeting conserved epitopes

• Functional Conservation Assessment:

  • Use antibodies to immunoprecipitate MSS116 orthologs from different species

  • Compare interaction partners to determine which MSS116 functions are evolutionarily conserved

  • Analyze whether species with different intron content show corresponding differences in MSS116 complex composition

• Heterologous Complementation Studies:

  • Express MSS116 orthologs in S. cerevisiae Δmss116 strains

  • Use antibodies to confirm expression levels and localization of heterologous proteins

  • Correlate functional complementation with biochemical properties detectable by antibody-based methods

• Evolutionary Adaptation Investigation:

  • Compare MSS116 expression levels across species adapted to different environmental niches

  • Analyze whether temperature-dependent phenotypes correlate with changes in MSS116's association with other factors

  • Examine species with different mitochondrial translation requirements to determine if MSS116's role in translation shows corresponding specialization

These comparative approaches can reveal evolutionary patterns in mitochondrial gene expression regulation and help distinguish core conserved functions from species-specific adaptations in the MSS116 protein family.